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The Human Type I Interferon Receptor:
NMR Structure Reveals the Molecular Basis
of Ligand Binding
mia (CML) (Bukowski et al., 2002), and hepatitis C (Perry
and Jarvis, 2001). Other -IFNs have been approved
for treatment of additional hepatitis subtypes, chronic
malignant melanoma, follicular lymphoma, and genital
warts caused by the human papilloma virus. IFN is
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Rehovot 76100 FDA approved for the treatment of relapsing-remitting
Israel multiple sclerosis (Deonarin et al., 2002). However, effi-
cient treatment by IFNs is frequently hampered by vari-
ous side effects (e.g., toxicity), neutralizing antibodies
and cell resistance (Einhorn and Grander, 1996). TheSummary
efficacy of IFN treatment could be enhanced if these
undesirable effects could be prevented or reduced withThe potent antiviral and antiproliferative activities of
a more selective and optimized activity profile.human type I interferons (IFNs) are mediated by a sin-
Type I IFNs share a common receptor consisting ofgle receptor comprising two subunits, IFNAR1 and
two subunits, IFNAR1 (Uze et al., 1990) and IFNAR2IFNAR2. The structure of the IFNAR2 IFN binding ecto-
(Novick et al., 1994), which associate upon IFN bindingdomain (IFNAR2-EC), the first helical cytokine receptor
(Cohen et al., 1995). IFNAR2 is the major ligand bindingstructure determined in solution, reveals the molecular
component of the receptor complex, exhibiting nanomo-basis for IFN binding. The atypical perpendicular orien-
lar affinity to both IFN and IFN subtypes. This affinitytation of its two fibronectin domains explains the lack
is increased up to 20-fold upon formation of the ternaryof C domain involvement in ligand binding. A model
complex with IFNAR1 (Cohen et al., 1995). The extracel-of the IFNAR2-EC/IFN2 complex based on double
lular domain of IFNAR2 (IFNAR2-EC) was expressed inmutant cycle-derived constraints uncovers an exten-
E. coli. The purified and folded IFNAR2-EC was foundsive and predominantly aliphatic hydrophobic patch
to be a stable protein, which retains the full bindingon the receptor that interacts with a matching hy-
activity of IFNAR2 and inhibits the antiviral activity ofdrophobic surface of IFN2. An adjacent motif of alter-
IFN2 by competing with the cellular IFN receptor fornating charged side chains guides the two proteins
IFN binding (Piehler and Schreiber, 1999a).into a tight complex. The binding interface may ac-
count for crossreactivity and ligand specificity of the The structures of IFNAR1 and IFNAR2, both class II
receptor. This molecular description of IFN binding helical cytokine receptors (HCRs), have not been solved
should be invaluable for study and design of IFN-based to date. The backbone resonances of IFNAR2-EC were
biomedical agents. assigned, and residues involved in IFN binding were
identified, by following ligand binding-induced changes
in IFNAR2-EC chemical shifts (Chill et al., 2002). ThisIntroduction
investigation, as well as mutagenesis (Lewerenz et al.,
1998; Piehler and Schreiber, 1999b) and immunoblock-Type I interferons (IFNs) are a family of homologous
ing (Chuntharapai et al., 1999) studies, located the IFNhelical cytokines that elicit potent antiviral and antiprolif-
binding site on three segments of the N-terminal domainerative cellular responses. IFN binding to its receptor
of IFNAR2-EC, including residues 44–52, 74–82, andtriggers a cascade of events, activating a number of
100–104. Residues of IFN ligands contributing to theproteins that inhibit viral replication and cell growth and
binding energy were identified as well (Piehler et al.,control apoptosis (Stark et al., 1998). IFNs are essential
2000; Runkel et al., 2000). Models for IFNAR2-EC basedfor the survival of higher vertebrates because they pro-
on its limited homology with tissue factor (TF; 21% iden-vide an early line of defense against viral infection, hours
to days before the immune response (Stark et al., 1998). tity) (Harlos et al., 1994), as well as other helical cytokine
This family of cytokines consists of about fifteen differ- receptors, such as the class II IFN receptor (IFNR;
ent IFN isotypes, typically exhibiting 80% sequence 17% identity) (Walter et al., 1995) and the class I growth
homology, IFN, exhibiting 30% identity to a consensus hormone receptor (GHR; 14% identity) (de Vos et al.,
IFN sequence, and IFN (Pestka et al., 1987). The struc- 1992), have been proposed (Chill et al., 2002; Piehler
tures of IFN2a (Klaus et al., 1997), IFN2b (Radhakrish- and Schreiber, 1999b). One such model was used to
nan et al., 1996), and IFN (Karpusas et al., 1997) have dock the IFN2 ligand into its binding site on IFNAR2-
been previously determined, showing IFNs to comprise EC with double mutant cycle data (Roisman et al., 2001).
a bundle of five long and nearly parallel  helices. However, the accuracy of the IFNAR2-EC models was
IFNs are currently the human proteins most widely severely limited by the low sequence homology between
used as therapeutic agents, having been approved to receptors of this family and several insertions and dele-
treat various types of cancer and viral diseases. IFN2 is tions in their sequences (seven insertions and deletions
used to treat hairy cell leukemia, AIDS-related Kaposi’s involving 32 residues for IFNR, the most similar recep-
sarcoma (Kirkwood, 2002), chronic myelogenous leuke- tor). The model of IFNAR2-EC was improved with NMR-
derived secondary structure information (Chill et al.,
2002). Nevertheless, the difficulties in modeling IFNAR2-*Correspondence: jacob.anglister@weizmann.ac.il
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EC have frustrated attempts to understand binding of Table 1. Structural Statistics for IFNAR2-ECa
IFN ligands by their receptor on a molecular level.
NMR Distance RestraintsOne of the major issues in IFN research is how the
Total interresidue restraints 1876versatile IFNAR2 specifically binds different IFN sub-
Sequential (|i  j|  1) 561types, thereby transducing different cellular responses
Medium range (1  |i  j|  5) 280(Mogensen et al., 1999). The relative contribution of both
Long range (|i  j|  5) 1035receptor subunits to ligand crossreactivity and signaling
Hydrogen bond restraintsb 134
specificity is currently unclear. Previous studies have NOE violations (A˚)
suggested partially overlapping binding sites upon Maximum single violation 0.5
Rmsd of NOE violationc 0.055 	 0.001IFNAR2 for the IFN and IFN subtypes and different
contributions of specific residues to the exhibited affin- Dihedral Angle Restraints
ity. Mutations of human IFNAR2 residues RE77, RW100,
Total dihedral restraints 180RI103, and RD104 abolished response to IFN2 with no
Experimental (φ) 88
effect upon IFN binding (Chuntharapai et al., 1999). TALOS derived (φ,
) 92
(Residues of IFNAR2-EC, IFN2, and IFN are preceded Dihedral angle violations ()
by superscripts R, , and , respectively, throughout Maximum single violation 5
Rmsd of dihedral violation 0.760 	 0.036the text.) Schreiber and coworkers found that, while
RT44, RI45, and RM46 are the key residues for IFN2 Deviation from Idealized Geometryd
binding (with some additional contribution from RS47,
Bond lengths (A˚) 0.004 	 0.000RK48, RH76, RE77, RW100, and RI103), RI45 and RW100
Bond angles () 0.600 	 0.010
are the major contributors to IFN binding (with smaller Improper angles () 0.560 	 0.016
contribution by residues RT44, RM46, RS47, and RI103)
Mean Rmsd Values (A˚)(Piehler and Schreiber, 1999b). Furthermore, important
Backbone 0.67differences between IFN subtypes correlated to signal-
Heavy atoms 1.12ing profiles have been identified on the opposite face of
Backbone (2 structure) 0.50the ligand, a surface postulated to interact with IFNAR1
Heavy atoms (2 structure) 0.90(Deonarin et al., 2002; Runkel et al., 2000).
a Excluding N-terminal residues 1–11 and C-terminal residuesTo examine IFN binding and signaling at the molecular
203–212.level, we solved the structure of the 25 kDa IFNAR2-EC
b Each hydrogen bond was defined by a pair of distance restraints,by multidimensional NMR. This first solution structure
dNH-O  2.05 A˚ and dN-O  2.9 A˚.of a hematopoietic receptor establishes an atypical per- c Distance root-mean-square deviations (rmsd) are from the upper
pendicular orientation and a well-structured hinge re- limit of the restraint and are calculated relative to the mean structure.
gion between the two fibronectin domains of unbound d Idealized geometries are based upon CNS parameters (parallhdg.
pro).IFNAR2. The IFNAR2-EC/IFN2 complex was then mod-
eled with the structures of IFNAR2-EC solved in the
present study and IFN2 solved previously by NMR
fibronectin domains are characterized by seven (Klaus et al., 1997). The docking of IFN into the IFNAR2-
strands arranged in a  sandwich, made of sheets ABEEC binding site is based on four intermolecular con-
and CCFG. Two disulfide bonds found in IFNAR2-EC,straints derived from double mutant cycle (DMC) mea-
RC58-RC66 and RC180-RC200, are conserved in bothsurements (Roisman et al., 2001). Our findings reveal
IFNR and TF. A third disulfide bond, RC12-RC95, con-that the receptor binding site is formed by an extensive
necting the two  sheets of the N domain, is unique toand predominantly aliphatic hydrophobic patch, which
IFNAR2-EC. Both domains are stabilized at either end byinteracts with a matching hydrophobic surface of IFN2.
a hydrophobic core, usually formed around a conservedAn adjacent pattern of charged residues of alternating
aromatic residue. IFNAR2-EC exhibits such hydropho-sign guides the ligand into its binding site. These results
bic cores around residues RW27, RY79, RF127, and RY179.account for the crossreactivity of IFNAR2-EC, as well
Sequence homology between IFNAR2-EC and otheras the lack of involvement of its C domain in the binding
HCRs is limited. Despite several differences in sequencesite, which distinguishes IFNAR2-EC from other HCRs.
and structure, IFNAR2-EC most resembles the receptor
for IFN. A superposition of the fibronectin N domains
of the two receptors reveals 65 equivalent C atomsResults
(out of a possible 82) with an rmsd of 1.8 A˚, while their
C domains (66 equivalent C atoms out of a possibleOverall Structure of IFNAR2-EC
The structure of IFNAR2-EC was determined at a root- 85) superimpose at 1.9 A˚ rmsd. Notable differences be-
tween the two receptors are the additional  bulge onmean-square deviation (rmsd) of 0.67 A˚ for backbone
atoms (Table 1). Over 95% of residues 11–203 appear the GN  strand, longer BCC loop, and additional C181-
C186 disulfide bond present in IFNR. ( strand letteringin favorable regions of a Ramachandran plot. Terminal
residues 1–11 and 206–212 are unstructured, as indi- follows immunoglobulin nomenclature, domains are de-
noted by a subscript N or C, and loops are designated bycated by the lack of long-range NOE contacts for this
region. Residues 13–99 of the N-domain and residues their flanking  strands.) Although class II HCRs typically
lack the “WSXWS” box appearing in class I receptors111–203 of the C domain form two fibronectin type III
modules, connected by a linker segment (residues 100– (Bazan, 1990), residues 90–94 of IFNAR2-EC (TTLFS)
preceding the GN strand adopt its characteristic polypro-110), which includes a typical  helix (Figure 1). Both
Molecular Basis of IFN Receptor Ligand Binding
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Figure 1. Solution Structure of IFNAR2-EC
 strands and  helices are shown in blue
and red, respectively. N- and C-fibronectin
domains referred to in the text are denoted.
Residues 1–9 of the N terminus and 207–212
of the C terminus are omitted for clarity.
(A) Stereo view of an ensemble of 22 superim-
posed lowest-energy NMR-derived back-
bone traces of IFNAR2-EC generated with the
program MOLMOL (Koradi et al., 1996).
(B) Ribbon representation of the average min-
imized structure of IFNAR2-EC generated by
InsightII (Accelrys).
line type II backbone conformation. This  bulge corre- region. In light of the perpendicular domain orientation
sponds to homologous segments in IFNR (residues that we observe for IFNAR2-EC, classification of HCRs
93–97, ESAYA) and IL-10R1 (residues 87–91, HSQWT). according to interdomain angle must be reassessed.
However, the highly basic motif of the FN  strand in- This perpendicular orientation is dictated by interac-
volved in the characteristic cation- stacking interaction tions of hinge region residues RS106–RE108 with both
is conspicuously absent in IFNAR2-EC. Overall, while domains (Figure 2). These residues form a strand paral-
sharing the common double fibronectin domain fold, lel to the AN  strand, a motif conserved in both IFNR
IFNAR2-EC exhibits significant structural differences (Walter et al., 1995) and IL-10R1 (Josephson et al., 2001).
when compared to the family of HCRs. The contact between the hinge region and the C domain
is stabilized by hydrophobic interactions of RF107 with
residue RL139 from the RBCC loop and side chain interac-Interdomain Orientation of IFNAR2-EC
tions of RS106 and RE108 with residues RI194 and RS196A striking feature of IFNAR2-EC is the mutually perpen-
from the RFGC loop. The adjacent Pro-Pro motif (residuesdicular orientation of its two domains. Class II HCRs
109–110) further rigidifies the interdomain hinge regionwere previously believed to exhibit an interdomain angle
and joins the two parallel  strands in stabilizing theof 120, on the basis of the X-ray structures of IFNR
perpendicular interdomain orientation. Furthermore,(Walter et al., 1995) and the related TF (Harlos et al.,
side chains of the ABN  turn (residues RN20–RF21) pro-1994). However, in IL-10R1, a recently reported X-ray
trude from the N-domain and interact with the turnstructure of this family, the domains are perpendicularly
formed by residues RP128–RI130 of the C domain.oriented (Josephson et al., 2001). Our structure indicates
The perpendicular orientation of IFNAR2-EC domainsthat the C domain of IFNR must be rotated by 25
affects the receptor surface presented for ligand bind-about an axis passing through the hinge region to super-
ing. The RBCC (residues 131–139) and RFGC (residuesimpose upon the analogous domain in IFNAR2-EC. Sig-
187–194) loops are retracted from the vicinity of thenificantly, measurement of 1DNH residual dipolar cou-
ligand binding site, while these loops are active partici-plings (RDCs) for each of its domains (data not shown)
pants in the binding site of other HCRs (Clackson et al.,independently validates the interdomain orientation ob-
1998; Josephson et al., 2001; Walter et al., 1995). Thistained from the NOE data. Moreover, the observation of
significant RDCs testifies to the rigidity of the hinge is in keeping with the lack of involvement of the IFNAR2
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The large hydrophobic surface is surrounded by a ring
of polar and charged residues, including RE84, RS96,
RH97, RN98, RD104, RD138, and RD189, which delimit the
hydrophobic patch. The right side of this ring exhibits
a distinct pattern of charged residues of alternating sign,
comprising residues RE50, RK48, and RE77 and polar
residue RH76. A hydrophobic core formed on the oppo-
site face of the  sheet around aromatic residues RY43,
RW72, and RY79 interacts with residues RI45, RL68, RF99,
and RL101, thus stabilizing the entire binding site
structure.
Modeling of the IFNAR2-EC/IFN2 Complex
with Double Mutant Cycle Constraints
It is generally accepted that a small number of experi-
mentally obtained intermolecular constraints is suffi-
cient to predict, with reasonable accuracy, the complex
between two proteins, provided no major structural
changes accompany its formation (Clore, 2000). This
condition is satisfied for IFNAR2-EC, since changes in
chemical shifts induced by IFN2 binding were limited
to the combining site region (Chill et al., 2002). Double
mutant cycle (DMC) measurements have been used to
correlate the contributions of specific residues to the
binding affinity in protein-protein interactions (Schreiber
and Fersht, 1995). These correlations, when interpreted
as interresidue spatial proximities, have been used to
predict the structure of several protein-protein com-
Figure 2. Detailed View of the Interdomain Interface of IFNAR2-EC plexes (Ackermann et al., 1998; Zvi et al., 2000). We
A network of interactions between residues of two fibronectin do- therefore used the four most significant previously iden-
mains and the hinge region confers an90 interdomain angle upon tified DMC constraints (Roisman et al., 2001; shown
IFNAR2-EC. Backbone segments are depicted as blue ribbons and in Table 2) to drive a simulated-annealing rigid-body
labeled as in the text. Side chains contributing to these interactions
docking algorithm, thereby modeling the IFNAR2-EC/are shown as sticks. The backbone of the BCC loop (containing
IFN2 complex. A fifth constraint, incompatible with theresidue L139) is omitted for clarity.
structure of IFNAR2-EC, was omitted from the calcula-
tions. This docking algorithm yields a complex with an
C domain in ligand binding. In addition, the exposure rmsd of 1.0 A˚ for the superposition of all backbone atoms
of the interdomain hinge  helix is increased, accounting in structured segments of the N domain of IFNAR2-EC
for the importance of residues RW100, RI103, and RD104 and IFN2 (Figure 4A).
for ligand affinity. Analysis of the obtained complex shows that over
800 A˚2 of IFNAR2-EC are buried upon ligand binding,
Structure of the IFNAR2-EC Binding Site 75% of which are contributed by residues RM46, RS47,
Our previous analysis of the changes in IFNAR2-EC RP49, RH76, RE77, RW100, and RI103. All three segments
chemical shifts induced upon IFN2 binding mapped of the binding site closely contact the IFN2 ligand (Fig-
the ligand binding site to a contiguous surface upon the ure 4B). The RCCN loop protrudes into a groove formed
N domain of the receptor (Chill et al., 2002). Juxtaposing by the AB loop and E helix, contributing over 50%
these changes upon the structure of IFNAR2-EC locates of the decrease in surface accessibility. The REFN loop
the receptor binding site to the anterior face of the contributes approximately 25% of the surface buried
RCCFGN  sheet (Figure 3A). Residues contributing to upon binding, interacting with the E helix. The receptor
the binding site are located on the RCCN (residues 44–52) interdomain helix interacts with the A helix of the ligand
and REFN (residues 74–82) loops and the  helix in the and forms 20% of the buried surface. In the binding
interdomain hinge (residues 100–104). The most striking surface on IFN2, the A helix, AB loop, and E helix
feature of the IFNAR2-EC binding surface, which mea- contribute 20%, 30%, and 45%, respectively, of the
sures approximately 23  20 A˚2, is a motif of parallel 650 A˚2 buried upon binding. The change in surface ac-
hydrophobic and hydrophilic striations. Residues RM46, cessibility in IFN2 is evenly distributed throughout the
RP49, RL52, RV80, RV82, RW100, and RI103 form an elon- binding site, with only one residue (R149) contributing
gated hydrophobic patch that spans the binding site. over 10% of the buried surface, whereas IFNAR2-EC
Of interest is the relative absence of aromatic residues has five such “hotspot” residues.
in the IFNAR2-EC binding site, with W100 as the sole
exception. In contrast, this large hydrophobic patch is The IFNAR2-EC/IFN2 Complex Reveals a Highly
absent, and aromatic, rather than aliphatic, side chains Compatible Binding Interface
make major contributions to ligand binding in the closely A detailed analysis of the binding interface is facilitated
by an open-book representation of the IFNAR2-EC/related IFNR, IL-10R1, and GHR (Figures 3B–3D).
Molecular Basis of IFN Receptor Ligand Binding
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Figure 3. The IFNAR2-EC Binding Site and Comparison to Homologous Helical Cytokine Receptors
Binding site residues are labeled and colored as follows: green, aliphatic; dark green, aromatic, red and blue, negatively and positively charged
residues, respectively; light blue, histidine; cyan, asparagine and glutamine; orange, serine and threonine.
(A) The IFNAR2-EC binding site and surroundings, demonstrating the hydrophobic and hydrophilic striations and the pattern of charge
distribution. The binding site (as defined by ligand-induced chemical shift changes) is delimited in black.
(B–D) Binding sites of three helical cytokine receptors, (B) IFNR, (C) IL-10R1, and (D) GHR. Binding sites are defined by loss of surface
accessibility upon complex formation. Receptors are rotated to facilitate viewing of the binding sites.
IFN2 complex (Figure 5A). The striated motif observed sumed to be unprotonated at a pH above 7.5 (where
binding is strongest) and, as suggested by the pH de-for the IFNAR2-EC binding surface interacts with a
highly complementary array of hydrophobic and hydro- pendence of the dissociation of the complex (Piehler
and Schreiber, 1999a), serves as an acceptor for the sidephilic patches on the binding surface of IFN2. Residues
RE50, RK48, and RE77 of the hydrophilic strip interact chain hydroxyl proton of S152. The resulting overall
pattern of four intermolecular electrostatic interactionswith a matching array of alternating charges upon IFN2
formed by residues R33, D35, and R149. RH76 is as- of alternating polarity on the surface of both receptor
and ligand is particularly striking (Figure 5B). At the heart
of the binding interface are the two complementary hy-
Table 2. Intermolecular Constraints Used in Modeling the drophobic strips, with receptor residues RM46, RP49,
IFNAR2-EC/IFN2 Complexa,b RV80, RV82, RW100, and RI103 of the anterior face of the
RCCFGN  sheet interacting with IFN2 residues M16IFNAR2-EC IFN2
and A19 of the A helix, L26 and L30 of the AB loop, and
RM46c R144 A145 and M148 of the E helix. The guanido moietiesRK48Nd D35Od
of both arginine residues R22 and R144 are orientedRH76N/Nd S152O
inward, interacting in the IFN2 core with E141. TheirRE77Od R149Nd
polymethylene side chains may therefore further con-a Constraints derived from double mutant cycle analysis (Roisman
tribute to the hydrophobic contact area. The role playedet al., 2001). All constraints used satisfied the condition |G| 
by the hydrophilic ring of residues surrounding the bind-3.0 kJ/mol. Of the five constraints originally used, the least signifi-
cant one (RY43/F27) was incompatible with the obtained structures ing site remains unclear.
and was not included in the docking algorithm.
b Intermolecular constraints were triply weighted compared with in- Binding Site Electrostaticstramolecular constraints during the docking algorithm.
A curious feature of the binding site is a disproportionatec The hydrophobic interaction between RM46 and R144 was inter-
presence of histidine residues, including RH76, whichpreted as an ambiguous distance constraint of 2.9 A˚ between side
chain protons. actively participates in binding, and RH97 and RH187,
d Electrostatic interactions were interpreted as a distance of 2.9 A˚ which border the binding site. These residues cause a
between donor and acceptor atoms. Ambiguous constraints were dramatic change in electrostatic potential of the
utilized when appropriate.
IFNAR2-EC binding surface as a function of pH, from a
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between samples at pH 8 (at which all NMR measure-
ments were conducted) and pH 7.2 and visible precipita-
tion at pH 6.7. While surprising for a protein with 14
excess negative charges, this behavior could be ex-
plained by the pH-induced increase in hydrophobic
character of the binding surface on IFNAR2-EC. Thus,
the overall electrostatic character of the binding surface
of IFNAR2-EC may be responsible for the tight complex
it forms with IFN ligands.
Both the IFN (Fischer et al., 1988) and the type I
IFN signaling complexes (Zoon et al., 1983) have been
shown to undergo ligand-dependent endocytosis and
then complex dissociation and cellular degradation of
the ligand. The acidic endosomal pH has been impli-
cated in the dissociation of many such signaling com-
plexes (Mukherjee et al., 1997), in some cases by trig-
gering a conformational change in the complex (DiPaola
and Maxfield, 1984). The histidine cluster in the IFNAR2-
EC binding site may provide the molecular mechanism
for dissociation of the internalized IFNAR2/IFN2 com-
plex. Protonation of the histidine residues would likely
destabilize the complex by repelling the IFN2 binding
surface. Further experiments are necessary to explore
the role of electrostatics in the cellular recycling of the
type I IFN receptor.
Discussion
Structural Comparison with Other Helical
Cytokine Receptors
The crystal structures of TF (Harlos et al., 1994) and two
class II HCR ectodomains, IFNR (Walter et al., 1995)
and IL-10R1 (Josephson et al., 2001), have been pre-
viously determined. While sharing the same double fi-
bronectin domain fold, these four proteins exhibit low
levels of sequence homology. A comparison of IFNAR2-
EC to the other proteins reveals 7–12 insertions or dele-
tions, involving over 15% of their sequences. The vast
majority of these occur in loop segments, including dele-
tions in the loops that form the binding site. These fac-
tors have severely undermined previous attempts to
model the structure of IFNAR2-EC. Two previously pro-Figure 4. The IFNAR2-EC/IFN2 Complex
posed models for IFNAR2-EC, one based on sequence(A) Average ribbon structure of the complex between IFNAR2-EC
homology (Piehler and Schreiber, 1999b) and the other(blue) and IFN2 (red).  strands of IFNAR2-EC and helices of IFN2
are labeled. Regions of IFN2 involved in binding to the receptor improved with NMR-derived secondary structure data
are highlighted in orange. (Chill et al., 2002), demonstrate this clearly. Sequence
(B) Detailed representation of the IFNAR2-EC/IFN2 interface. The homology is particularly low in the C domain, and model-
N domain CCFG  sheet is shown as blue ribbons, and the receptor
ing fares poorly, as the models superimpose upon theside chains interacting with IFN2 are depicted as sticks. The sur-
NMR structure at 6.6 and 3.7 A˚, respectively. Further-face of IFN2 domains interacting with the receptor and the underly-
more, a superposition of the 23 residues of the NMR-ing backbone trace are shown in orange. Receptor  strands, IFN2
helices, and highlighted residues are labeled. determined binding site yields rmsd values of 3.3 and
2.6 A˚ between the models and the solution structure.
The main source of structural variance in the binding
highly negatively charged surface at pH 8 (unprotonated site, the RCCN loop, is highly detrimental to models of
histidines) to nearly uncharged at pH 5 (protonated histi- the IFNAR2-EC/IFN2 complex, since this loop is also
dines) (Figure 6). This change is unparalleled in other the major contributor to the binding interface. The diffi-
regions of the receptor. The affinity of IFNAR2-EC to culties in modeling IFNAR2-EC underline the impact of
IFN2 has been shown to be maximal at a pH above the structure presented in this study upon our under-
7.5, and its significant decrease at slightly acidic pH standing of IFNAR2-EC and its binding to IFNs.
values has been attributed to a histidine residue with
an elevated pKa of 6.7 (Piehler and Schreiber, 1999b). The Structure of the Binding Interface Accounts
We have observed a strong pH dependence of the solu- for Mutagenesis Results
bility of free IFNAR2-EC, manifested as a 25%–35% Mutations of residues involved in the IFN2 binding site
would be expected to compromise its structure, thusdecrease in amide proton transverse relaxation times
Molecular Basis of IFN Receptor Ligand Binding
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Figure 5. Open Book Representation of the IFNAR2-EC/IFN2 Binding Site
(A) Binding surfaces of IFNAR2-EC (left) and IFN2 (right) are portrayed in spacefill mode. Highlighted IFNAR2-EC residues exhibit IFN2-
induced changes in chemical shift. Highlighted IFN2 residues lose over 10% of accessible surface upon binding. Residues are colored as
in Figure 3. Thin lines connect residues with double mutant cycle energies above 3 kJ (Roisman et al., 2001) and involved in constraints used
in the docking algorithm.
(B) Schematic representation of the binding sites demonstrating their compatibility.
hindering the interaction between IFNAR2-EC and of the binding site, thereby decreasing IFN2 affinity
(Chuntharapai et al., 1999; Lewerenz et al., 1998; PiehlerIFN2. Analysis of the binding site structure presented
and Schreiber, 1999b) (Figure 7A). Mutations of polarherein reveals a good correlation with experimental mu-
residues, including RK48A, RE50A, RH76A, and RE77A,tagenesis data. The hydrophobic strip of the binding
adversely affect IFN2 binding and reduce the comple-surface coincides with the largest hydrophobic patch in
mentarity between ligand and receptor.IFNAR2-EC (Piehler et al., 2000). The fact that the RM46A
The model of the IFNAR2-EC/IFN2 complex identi-mutation is the single mutation most detrimental to
fies a second category of mutations that reduce ligandIFN2 binding is consistent with its central position in
affinity by affecting residues lacking direct contact withthis binding surface. Similarly, the RV80A, RW100A, and
the ligand, but playing an active role in stabilizing theRI103A mutations significantly lower the hydrophobicity
binding site conformation. The IFN2 affinity of the
RT44A mutant drops significantly because the absence
of the -methyl group destabilizes the conformation of
the RCCN loop fold (Figure 7A). Four mutations of resi-
dues from the opposite face of the RCCFGN  sheet,
RY43A, RI45A, RW72A, and RY79A, do not directly contact
IFN2 yet exert moderate to strong effects upon IFN2
affinity (Lewerenz et al., 1998; Piehler and Schreiber,
1999b). Residues RY43 and RY79 pack tightly against the
indole and benzene ring of RW72, respectively, stabiliz-
ing the interface between the RCCN and REFN binding
loops with this unique aromatic stacking pattern. RI45
further contributes to this hydrophobic core by inter-
acting with the opposite face of the RY79 aromatic ring
(Figure 7B). This structural effect is clearly demonstrated
by the RW72A and RY79A mutations, which have been
shown to produce poorly folded and misfolded proteins,
respectively (Piehler and Schreiber, 1999b).
Figure 6. Electrostatics of the IFNAR2-EC Binding Site
A similar agreement is observed between mutagene-
The electrostatic potential for the surface of the IFNAR2-EC binding
sis data for the binding surface on IFN2 and our modelsite was calculated with the Delphi module of InsightII (Accelrys).
of the binding interface. Of the 12 IFN2 residues shownThe surface is shown at pH 5 (left) and pH 8 (right). A pKa value of
to significantly (more than 4-fold) decrease IFNAR2-EC6.0 was assumed for histidine residues. Blue, gray, and red shades
represent positive, neutral, and negative potentials, respectively. binding (Piehler et al., 2000), 11 (all but L15) are located
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Figure 7. Detailed View of the Binding Site of IFNAR2-EC
(A) Frontal and (B) reverse views of the N domain CCFG  sheet. Both views highlight residues contributing to the hydrophobic strip of the
binding surface and residues forming its stabilizing hydrophobic scaffold. The four  strands are depicted as blue ribbons and labeled
appropriately.
in our NMR-determined binding site, including the six to the formation of their complexes with IFN and IL-
10, respectively.“hotspot” residues L30, R33, R144, A145, M148,
and R149. These residues are also conserved through- In binding all IFN isotypes as well as IFN, IFNAR2-
EC exhibits a crossreactivity that distinguishes it fromout all IFN subtypes. L15 is mostly buried in the struc-
other HCRs. This may be explained by the unique char-ture of IFN2, and its adverse effect upon complex for-
acter of its binding site. While aromatic residues typicallymation may reflect a structural role in stabilizing the A
form specific interactions with stringent spatial require-helix. The hydrophobic strip in our IFN2 binding surface
ments, the aliphatic side chains of the IFNAR2-EC bind-extends down the A helix to include residues M16 and
ing site may present a more malleable hydrophobic sur-A19. IFN isotypes exhibit only conservative substitu-
face, capable of accommodating the correspondingtions for these solvent-exposed residues, supporting
hydrophobic patch of different IFN ligands. In the ab-their involvement in the binding site. The methylene side
sence of aromatic side chains, correct spatial position-chain of R22 may further contribute to this hydrophobic
ing of the ligand may be maintained by the pattern ofsurface, although its low level of conservation indicates
charge distribution surrounding the hydrophobic patch.that it does not play a critical role in binding to the
Such electrostatic guiding is in keeping with the pre-receptor. The molecular view of the IFN binding mode
viously described paradigm for protein-protein interac-presented here provides, therefore, a comprehensive
tions (Schreiber and Fersht, 1996; Selzer and Schreiber,structural context for the interpretation of in vitro and
2001).cellular binding assays.
Interestingly, the single aromatic side chain in the
binding site (RW100) may be responsible for specific
Implications of Structure on Receptor recognition of IFN. IFN activity is abolished in the
Crossreactivity and Ligand Selectivity RW100A mutant, while IFN activity decreases only
A comparison between the binding sites of IFNAR2- 4-fold. The replacement of A19 of the A helix by W22
EC and other HCRs reveals two important differences in IFN may allow a favorable interaction between the
(Figure 3). The large hydrophobic patch spanning the aromatic rings of these two tryptophan residues (Piehler
binding site in IFNAR2-EC is not observed in IFNR, IL- et al., 2000). Furthermore, a second nonconservative
10R1, or GHR, whose binding site is typically a mosaic substitution observed in the A helix of IFN, K19 replac-
of hydrophobic and polar residues involved in intermo- ing M16, may join important sequence variations on
lecular contacts. Furthermore, these three counterparts the C helix in contributing to specific ligand recognition
of IFNAR2-EC are characterized by major contributions by IFNAR2-EC.
of aromatic residues to the binding energy, while the A comparison of D2O exchange rates between free
hydrophobic patch of IFNAR2-EC is predominantly ali- and complexed IFNAR2-EC demonstrated that ligand
phatic. In the GHR binding site, residues W104 and W169 binding is accompanied by an overall tightening of the
alone encompass 70% of lost surface accessibility N domain, but not the C domain. Notably, this effect
upon ligand binding (Clackson et al., 1998; de Vos et was not confined to the IFN2 binding site (Chill et al.,
al., 1992). Similarly, residues Y49, W56, W82, and W207 2002). This conformational flexibility of the N domain
may enhance the capability of the receptor to accommo-of IFNR and Y43, W48, and Y75 of IL-10R1 are essential
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date different ligands in the receptor binding site. The experimental data on the precise role of each binding
domain in the signaling complex, it lays the foundationsligand-induced tightening of the N domain may then be
involved in subsequent events of the signaling cascade. for further structural studies.
In summary, the unique structure and flexible character
of the IFNAR2-EC binding site account for its versatility Biological Implications
in binding multiple ligands. Two receptor subunits, IFNAR1 and IFNAR2, regulate
the activity of type I interferons (IFNs) in humans, thereby
mediating a host of cellular processes, including apo-Implications of Interdomain Orientation
ptosis and inhibition of viral replication and cell growthupon IFN Signaling
(Stark et al., 1998). IFNs have been the focus of extensive
Together with the recently determined X-ray structure
biomedical research and are widely used to treat various
of IL-10R1, the perpendicular interdomain orientation of
types of cancer and viral diseases (Deonarin et al., 2002).
IFNAR2-EC represents 50% of the known structures of
A structural understanding of ligand binding and speci-
class II HCRs. This disproves the common belief that the
ficity could greatly enhance the efficacy of such
interdomain angle of this class is120. The orientation
IFN-based therapies. Despite extensive efforts, difficul-
established for IFNAR2-EC obtained in solution is partic-
ties in crystallizing the membranal receptor chains and
ularly significant, since, unlike X-ray structures, it is un-
low homology within the helical cytokine receptor family
affected by crystal packing forces. NMR is well suited
have frustrated attempts to obtain information at the
for structure determination of multidomain macromole-
molecular level for the type I IFN receptor.
cules (Barbato et al., 1992), and this capability is
The structure of the IFNAR2 ectodomain (IFNAR2-
strengthened by the advent of residual dipolar-coupling
EC) reveals this molecular basis for IFN binding and
measurements (Bax et al., 2001).
signaling. The two fibronectin domains of IFNAR2-EC
The perpendicular interdomain orientation of IFNAR2-
are perpendicularly oriented, explaining the lack of
EC increases the exposure of the hinge region for inter-
involvement of the C domain in the binding site. This
action with IFN and at the same time retracts the C
result obtained for the free receptor in solution is particu-
domain from the vicinity of the binding site. This explains
larly important, since variations in interdomain angle
the lack of involvement of the C domain in ligand binding,
and domain rigidity have been studied in the context of
which is unique to IFNAR2-EC. Neither mutagenesis
signaling (Muller et al., 1998). The structure also repre-
(Lewerenz et al., 1998; Piehler and Schreiber, 1999b)
sents an important step toward determination of the
nor NMR (Chill et al., 2002) studies could identify a contri-
structures of type I IFN signaling complexes. We have
bution of the C domain to IFN binding, and the IFN2
demonstrated this by utilizing double mutant cycle-
affinities of IFNAR2-EC and a truncated polypeptide in-
derived constraints to dock the IFN2 ligand into its
cluding the N domain and hinge are practically indistin-
binding site upon IFNAR2-EC. The predominantly ali-
guishable (Roisman et al., 2001). The interdomain orien-
phatic hydrophobic binding patch of IFNAR2-EC is ca-
tation also resolves difficulties raised by a previous model,
pable of binding multiple ligands, guided electrostati-
in which the assumed 120 interdomain angle created a
cally by an adjacent motif of alternating charges. A
significant contact area between IFN2 and the C domain
similar array of hydrophobic and charged strips on
(Lewerenz et al., 1998; Piehler and Schreiber, 1999b).
IFN2 presents a highly complementary binding surface.
IFN signaling is contingent upon IFN-induced associa-
The structure also identifies receptor residues that as-
tion of IFNAR2 and IFNAR1. The extracellular domain
sume key roles in stabilizing the binding interface. The
of IFNAR1 comprises two linked IFNAR2-EC-like poly-
electrostatics of the binding site account for the ob-
peptides, D1 and D2, or four fibronectin domains. Al-
served pH dependence of binding affinity and may play
though the structural factors governing the formation of
a role in recycling of the IFN signaling complex. To-
this ternary signaling complex have yet to be deter-
gether, the structures of IFNAR2-EC and its complex
mined, a plausible mode of assembly may be suggested
with the IFN2 ligand provide a molecular understanding
from the results of this study and mutagenesis data
of IFN biochemistry, suggest a plausible assembly for
on the IFNAR1/IFN2 interface (Figure 8). The binding
its signaling complex, and lay the groundwork for further
surface of IFN2, comprising the A and E helices and
biological experimentation. In light of the increasing
the AB loop, binds to the N domain of IFNAR2, forming
therapeutical applicability of IFNs, these findings prom-
the binding interface described in this study. The oppo-
ise to be particularly valuable for future progress in this
site face of IFN2, comprising helices B and C, is
important field.
assumed to interact with IFNAR1. Sequence variations
in the C helix between IFN and IFN have been impli-
Experimental Procedurescated in mediating ligand-specific signaling by inter-
acting differently with the IFNAR1 binding site (Korn et NMR Sample Preparation
al., 1994). This binding surface has been located by IFNAR2-EC was expressed in appropriately labeled Celtone medium
(Spectragases) and purified as previously described (Chill et al.,mutagenesis at the cleft formed by the central two of the
2002). All NMR experiments were conducted at concentrations offour IFNAR1 fibronectin domains (Cutrone and Langer,
0.25–0.5 mM of IFNAR2-EC in 20 mM Tris buffer at pH 8 and 0.02%2001). The orientation of D1 and D2, each modeled here
NaN3. Samples prepared in this manner included unlabeled IFNAR2-by molecular replacement with IFNAR2-EC as a tem-
EC, 15N-IFNAR2-EC in H2O, and 13C,15N-IFNAR2-EC samples in bothplate, enables them to interact with the B and C helices H2O and D2O. Weakly aligned samples of 15N-IFNAR2-EC in H2O
of IFN2, thereby forming the signaling complex (Figure were prepared in polyacrylamide gel (monomer/crosslinker ratio of
37.5:1) swelled with a solution of the protein as previously described8). While verification of this hypothesis awaits further
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Figure 8. Postulated Assembly of the Type I IFN Signaling Complex
Stereo view of a suggested organization of the ternary type I IFN signaling complex formed by IFN2 and both receptor subunits. The modeled
IFNAR2-EC/IFN2 complex appears as blue (IFNAR2-EC) and red (IFN2) ribbons, with their binding interface highlighted in orange. Each of
the two IFNAR1 200-residue domains (D1 and D2) is modeled on the basis of the structure of IFNAR2-EC and shown in surface representation.
Regions upon IFNAR1 and IFN2 postulated to interact in the signaling complex (Cutrone and Langer, 2001; Deonarin et al., 2002; Runkel et
al., 2000) are highlighted in purple. The association of the two receptor subunits triggers the IFN signaling cascade.
(Sass et al., 2000; Tycko et al., 2000). Longitudinal pressure was ment. NOE-derived constraints from each spectrum were calibrated
with the appropriate proton-proton distances with fixed geometryapplied on the swelled gel in a Shigemi NMR tube with the insert.
or of well-defined secondary structure. φ angle constraints were
derived from measured 3J couplings. The φ angle was constrainedNMR Spectroscopy
NMR spectra were acquired at 32–35C on Bruker 500 or 800 MHz to 65 	 25 for 3J values under 6 Hz and to 120 	 30 for 3J
values over 8 Hz. Additional angular constraints were obtained fromNMR spectrometers. Backbone assignment and measurement of
3JHNH couplings have been previously described (Chill et al., 2002). an analysis of backbone and 13C chemical shifts with the TALOS
program (Cornilescu et al., 1999). Hydrogen bonds were interpreted1H and 13C resonances of side chains were assigned by 3D HCCH-
COSY (Bax et al., 1990a) and 3D HCCH-total correlation spectros- as a pair of distance constraints, dNH-O  2.05 A˚ and dN-O  2.9 A˚.
All structure calculations employed version 1.1 of the CNS programcopy (TOCSY) (Bax et al., 1990b), HBHA(CBCACO)NH (Grzesiek and
Bax, 1993), and (H)CC-TOCSY-(CO)NH (Grzesiek et al., 1993) experi- (Bru¨nger et al., 1998). The structure of each domain of IFNAR2-
EC (including the hinge segment) was calculated separately withments acquired for a uniformly 15N/13C-labeled sample. Assignment
of protons of aromatic side chains was accomplished by 2D distance geometry and simulated annealing. Constraints were intro-
duced into the calculation in an iterative manner, with a previouslyCB(CGCD)HD and 2D CB(CGCDCE)HE experiments (Yamazaki et
al., 1993) acquired for a uniformly 15N/13C-labeled sample in D2O and calculated model (Chill et al., 2002) and in-house scripts assisting in
assignment of ambiguous NOEs. Superposition of the hinge regionsassisted by 2D homonuclear TOCSY (31 ms mixing time) and NOESY
(75 ms mixing time) acquired for a 0.7 mM unlabeled sample. Experi- yielded initial structures for the final refinement stage. The final
refinement included several simulated annealing steps and wasments used to derive NOE constraints included the aforementioned
homonuclear, 3D 15N-separated (Marion et al., 1989), and 3D 13C- based upon 1876 interresidual interproton distance, 134 hydrogen
bond, 88  angle, 92 TALOS-derived backbone dihedral, and 109separated (Ikura et al., 1990) NOESY experiments, with mixing times
of 70–80 ms. [1H,15N]-RDCs were measured by comparing the DSSE- N-H RDC restraints. Structures were displayed with the InsightII
software package (Accelrys).[1H,15N]IPAP-HSQC spectrum (Cordier et al., 1999) acquired for iso-
tropic and aligned 15N-labeled samples. Data were processed and
analyzed with XWINNMR (Bruker) and the NMRPipe/NMRDraw (De- Molecular Docking and Modeling
IFN2 was docked into its binding site upon IFNAR2-EC using fourlaglio et al., 1995) software packages.
intermolecular distance constraints derived from analysis of double
mutant cycle experiments. All IFNAR2-EC backbone and side chainStructure Determination
Distance constraints were obtained from 3D 15N- or 13C-separated NOE constraints were upheld in the docking procedure. The back-
bone trace of IFN2 was fixed with 360 intra- and interhelix C-CNOESY experiments as well as the 2D NOESY homonuclear experi-
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distance constraints obtained from its previously published NMR Clore, G.M. (2000). Accurate and rapid docking of protein-protein
complexes on the basis of intermolecular nuclear Overhauser en-structure (Protein Data Bank accession code 1ITF) (Klaus et al.,
1997). Intermolecular constraints detailed in Table 2 were triply hancement data and dipolar couplings by rigid body minimization.
Proc. Natl. Acad. Sci. USA 97, 9021–9025.weighted. In the initial structures the ligand was randomly rotated
and positioned 20 A˚ away from the binding site. A simulated an- Cohen, B., Novick, D., Barak, S., and Rubinstein, M. (1995). Ligand-
nealing protocol was then used to model the structure of the induced association of the type I interferon receptor components.
IFNAR2-EC/IFN2 complex. The D1 and D2 domains of IFNAR1 Mol. Cell. Biol. 15, 4208–4214.
were modeled by aligning their sequences with that of IFNAR2-EC
Cordier, F., Dingley, A.J., and Grzesiek, S. (1999). A doublet-sepa-
and then by backbone coordinate replacement. This process, as
rated sensitivity-enhanced HSQC for the determination of scalar
well as calculation of surface accessibilities, was performed with
and dipolar one-bond J-couplings. J. Biomol. NMR 13, 175–180.
the program InsightII (Accelrys).
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